Correction to: Evolving treatments and outcomes in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a real-world study in China | Synapse
March 3, 2026Open Access
Correction to: Evolving treatments and outcomes in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a real-world study in China
Puntos clave
Treatment outcomes improve for patients with multiple myeloma who receive autologous stem cell transplantation, highlighting evolving therapies.
A notable find is the increased survival rates among patients over recent years, with data collected from various centers.
This real-world study examines outcomes specifically for multiple myeloma patients who underwent stem cell transplantation, utilizing registry data.
The findings support the trend of better outcomes for patients, suggesting a need for continuous refinement in treatment approaches.